Prof. Dr. ID: 37856

Nicolaus-Martin Kröger

Head of Clinic

graph of relations

Publications

  1. 2014
  2. IMWG consensus on risk stratification in multiple myeloma

    Chng, W. J., Dispenzieri, A., Chim, C-S., Fonseca, R., Goldschmidt, H., Lentzsch, S., Munshi, N., Palumbo, A., Miguel, J. S., Sonneveld, P., Cavo, M., Usmani, S., Durie, B. G. M., Avet-Loiseau, H. & International Myeloma Working Group, 01.02.2014, In: LEUKEMIA. 28, 2, p. 269-77 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice

    Ruutu, T., Gratwohl, A., de Witte, T., Afanasyev, B., Apperley, J., Bacigalupo, A., Dazzi, F., Dreger, P., Duarte, R., Finke, J., Garderet, L., Greinix, H., Holler, E., Kröger, N., Lawitschka, A., Mohty, M., Nagler, A., Passweg, J., Ringdén, O., Socié, G., Sierra, J., Sureda, A., Wiktor-Jedrzejczak, W., Madrigal, A. & Niederwieser, D., 01.02.2014, In: BONE MARROW TRANSPL. 49, 2, p. 168-73 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4+ and CD8+ T-cell responses in multiple myeloma patients

    Reinhard, H., Yousef, S., Luetkens, T., Fehse, B., Berdien, B., Kröger, N. & Atanackovic, D., 01.01.2014, In: BLOOD CANCER J. 4, p. e212

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation

    Wolschke, C., Zabelina, T., Ayuketang, F. A., Alchalby, H., Berger, J., Klyuchnikov, E., Pein, U-M., Schumacher, S., Amtsfeld, G., Adjallé, R., Wortmann, F., Lellek, H., Randenborgh, A., Zander, A. & Kröger, N., 01.01.2014, In: BONE MARROW TRANSPL. 49, 1, p. 126-30 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation

    de Lima, M., Porter, D. L., Battiwalla, M., Bishop, M. R., Giralt, S. A., Hardy, N. M., Kröger, N., Wayne, A. S. & Schmid, C., 01.01.2014, In: BIOL BLOOD MARROW TR. 20, 1, p. 4-13 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis

    Lehmberg, K., Albert, M. H., Beier, R., Beutel, K., Gruhn, B., Kröger, N-M., Meisel, R., Schulz, A., Stachel, D., Woessmann, W., Janka, G. & Müller, I., 01.01.2014, In: HAEMATOLOGICA. 99, 1, p. 180-4 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleTransferpeer-review

  8. Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome

    Nagler, A., Labopin, M., Berger, R., Bunjes, D., Campos, A., Socié, G., Kröger, N., Goker, H., Yakoub-Agha, I., Shimoni, A., Mohty, M. & Rocha, V., 2014, In: BONE MARROW TRANSPL. 49, 5, p. 628-33 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Selected CD34 Stem cells for Graft Engineering: 34 Case Reports in Hematopoietic Stem Cell Transplantation

    Aversa, F. & Kroger, N., 2014, 1 ed. Stuttgart: Georg Thieme Verlag KG.

    Research output: Book/anthologyCollected edition/anthology

  10. 2013
  11. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies

    Avigan, D., Hari, P., Battiwalla, M., Bishop, M. R., Giralt, S. A., Hardy, N. M., Kröger, N., Wayne, A. S. & Hsu, K. C., 01.12.2013, In: BIOL BLOOD MARROW TR. 19, 12, p. 1661-9 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting

    Atanackovic, D., Reinhard, H., Meyer, S., Spöck, S., Grob, T., Luetkens, T., Yousef, S., Cao, Y., Hildebrandt, Y., Templin, J., Bartels, K., Lajmi, N., Stoiber, H., Kröger, N-M., Atz, J., Seimetz, D., Izbicki, J. R. & Bokemeyer, C., 01.12.2013, In: HUM VACC IMMUNOTHER. 9, 12, p. 2533-42 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell Transplantation: a report from the Acute Leukemia Working Party of EBMT

    Schmidt-Hieber, M., Labopin, M., Beelen, D., Volin, L., Ehninger, G., Finke, J., Socié, G., Schwerdtfeger, R., Kröger, N., Ganser, A., Niederwieser, D., Polge, E., Blau, I. W. & Mohty, M., 07.11.2013, In: BLOOD. 122, 19, p. 3359-64 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: introduction

    Wayne, A. S., Giralt, S., Kröger, N. & Bishop, M. R., 01.11.2013, In: BIOL BLOOD MARROW TR. 19, 11, p. 1534-6 3 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  15. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation

    Gress, R. E., Miller, J. S., Battiwalla, M., Bishop, M. R., Giralt, S. A., Hardy, N. M., Kröger, N., Wayne, A. S., Landau, D. A. & Wu, C. J., 01.11.2013, In: BIOL BLOOD MARROW TR. 19, 11, p. 1537-45 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous Transplantation: a study by the European Group for Blood and Marrow Transplantation

    Auner, H. W., Szydlo, R., van Biezen, A., Iacobelli, S., Gahrton, G., Milpied, N., Volin, L., Janssen, J., Nguyen Quoc, S., Michallet, M., Schoemans, H., El Cheikh, J., Petersen, E., Guilhot, F., Schönland, S., Ahlberg, L., Morris, C., Garderet, L., de Witte, T., Kröger, N. & Plasma Cell Dyscrasia Sub-committee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (EBMT), 01.11.2013, In: BONE MARROW TRANSPL. 48, 11, p. 1395-400 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation

    Gerull, S., Stern, M., Apperley, J., Beelen, D., Brinch, L., Bunjes, D., Butler, A., Ganser, A., Ghavamzadeh, A., Koh, M. B., Komarnicki, M., Kröger, N., Maertens, J., Maschan, A., Peters, C., Rovira, M., Sengeløv, H., Socié, G., Tischer, J., Oneto, R., Passweg, J. & Marsh, J., 01.11.2013, In: HAEMATOLOGICA. 98, 11, p. 1804-9 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. SETBP1 mutation analysis in 944 patients with MDS and AML

    Thol, F., Suchanek, K. J., Koenecke, C., Stadler, M., Platzbecker, U., Thiede, C., Schroeder, T., Kobbe, G., Kade, S., Löffeld, P., Banihosseini, S., Bug, G., Ottmann, O., Hofmann, W-K., Krauter, J., Kröger, N., Ganser, A. & Heuser, M., 01.10.2013, In: LEUKEMIA. 27, 10, p. 2072-5 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  19. From nuclear to a global Family: more donors for MDS

    Kröger, N., 12.09.2013, In: BLOOD. 122, 11, p. 1848-50 3 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  20. Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change

    Christopeit, M., Kuss, O., Finke, J., Bacher, U., Beelen, D. W., Bornhäuser, M., Schwerdtfeger, R., Bethge, W. A., Basara, N., Gramatzki, M., Tischer, J., Kolb, H-J., Uharek, L., Meyer, R. G., Bunjes, D., Scheid, C., Martin, H., Niederwieser, D., Kröger, N., Bertz, H., Schrezenmeier, H. & Schmid, C., 10.09.2013, In: J CLIN ONCOL. 31, 26, p. 3259-71 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Hematopoietic SCT in Europe: data and trends in 2011

    Passweg, J. R., Baldomero, H., Bregni, M., Cesaro, S., Dreger, P., Duarte, R. F., Falkenburg, J. H. F., Kröger, N., Farge-Bancel, D., Gaspar, H. B., Marsh, J., Mohty, M., Peters, C., Sureda, A., Velardi, A., Ruiz de Elvira, C., Madrigal, A. & European Group for Blood and Marrow Transplantation, 01.09.2013, In: BONE MARROW TRANSPL. 48, 9, p. 1161-7 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Impact of physiological BM CD10+CD19+ B-cell precursors (haematogones) in the post-transplant period in patients with AML

    Christopeit, M., Heiland, A., Binder, M., Zabelina, T., Ayuketang, F. A., Horn, C., Haferlach, T., Bokemeyer, C., Kröger, N. & Bacher, U., 01.09.2013, In: BONE MARROW TRANSPL. 48, 9, p. 1257-9 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  23. Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation

    Schroeder, T., Fröbel, J., Cadeddu, R-P., Czibere, A., Dienst, A., Platzbecker, U., Bug, G., Uharek, L., Fenk, R., Germing, U., Kröger, N., Haas, R. & Kobbe, G., 01.09.2013, In: LEUKEMIA. 27, 9, p. 1910-3 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  24. Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

    Tefferi, A., Cervantes, F., Mesa, R., Passamonti, F., Verstovsek, S., Vannucchi, A. M., Gotlib, J., Dupriez, B., Pardanani, A., Harrison, C., Hoffman, R., Gisslinger, H., Kröger, N., Thiele, J., Barbui, T. & Barosi, G., 22.08.2013, In: BLOOD. 122, 8, p. 1395-8 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Donor choice according to age for allo-SCT for AML in complete remission

    Ayuketang, F. A., Zabelina, T., Wortmann, F., Alchalby, H., Wolschke, C., Lellek, H., Bacher, U., Zander, A. & Kröger, N., 01.08.2013, In: BONE MARROW TRANSPL. 48, 8, p. 1028-32 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Acute psychological stress increases peripheral blood CD3+CD56+ natural killer T cells in healthy men: possible implications for the development and treatment of allergic and autoimmune disorders

    Atanackovic, D., Nowottne, U., Freier, E., Weber, C. S., Meyer, S., Bartels, K., Hildebrandt, Y., Cao, Y., Kröger, N-M., Brunner-Weinzierl, M. C., Bokemeyer, C. & Deter, H-C., 01.07.2013, In: STRESS. 16, 4, p. 421-8 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Hematopoietic stem and progenitor cell mobilization in mice and humans by a first-in-class mirror-image oligonucleotide inhibitor of CXCL12

    Vater, A., Sahlmann, J., Kröger, N., Zöllner, S., Lioznov, M., Maasch, C., Buchner, K., Vossmeyer, D., Schwoebel, F., Purschke, W. G., Vonhoff, S., Kruschinski, A., Hübel, K., Humphrey, M., Klussmann, S. & Fliegert, F., 01.07.2013, In: CLIN PHARMACOL THER. 94, 1, p. 150-7 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study

    Gahrton, G., Iacobelli, S., Björkstrand, B., Hegenbart, U., Gruber, A., Greinix, H., Volin, L., Narni, F., Carella, A. M., Beksac, M., Bosi, A., Milone, G., Corradini, P., Schönland, S., Friberg, K., van Biezen, A., Goldschmidt, H., de Witte, T., Morris, C., Niederwieser, D., Garderet, L., Kröger, N. & EBMT Chronic Malignancies Working Party Plasma Cell Disorders Subcommittee, 20.06.2013, In: BLOOD. 121, 25, p. 5055-63 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

    Schroeder, T., Czibere, A., Platzbecker, U., Bug, G., Uharek, L., Luft, T., Giagounidis, A., Zohren, F., Bruns, I., Wolschke, C., Rieger, K., Fenk, R., Germing, U., Haas, R., Kröger, N. & Kobbe, G., 01.06.2013, In: LEUKEMIA. 27, 6, p. 1229-35 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Influenza virus-specific TCR-transduced T cells as a model for adoptive immunotherapy

    Berdien, B., Reinhard, H., Meyer, S., Spöck, S., Kröger, N-M., Atanackovic, D. & Fehse, B., 01.06.2013, In: HUM VACC IMMUNOTHER. 9, 6, p. 1205-16 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase

    Langer, F., Spath, B., Fischer, C., Stolz, M., Ayuketang, F. A., Kröger, N-M., Bokemeyer, C. & Ruf, W., 21.03.2013, In: BLOOD. 121, 12, p. 2324-35 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Evaluation of BM cytomorphology after allo-SCT in patients with MDS

    Christopeit, M., Ocheni, S., Haferlach, T., Miersch, K., Zabelina, T., Klyuchnikov, E., Binder, M., Ayuketang, F. A., Schafhausen, P., Zander, A. R., Bokemeyer, C., Kröger, N. & Bacher, U., 01.03.2013, In: BONE MARROW TRANSPL. 48, 3, p. 465-6 2 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  33. Comparative diagnostic performance of ¹⁸F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation

    Derlin, T., Peldschus, K., Münster, S., Bannas, P., Herrmann, J., Stübig, T., Habermann, C. R., Adam, G., Kröger, N-M. & Weber, C., 01.02.2013, In: EUR RADIOL. 23, 2, p. 570-8 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic Syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data

    Brand, R., Putter, H., van Biezen, A., Niederwieser, D., Martino, R., Mufti, G., Onida, F., Symeonidis, A., Schmid, C., Garderet, L., Robin, M., van Gelder, M., Finke, J., Bornhäuser, M., Kobbe, G., Germing, U., de Witte, T. & Kröger, N., 01.01.2013, In: PLOS ONE. 8, 10, p. e74368

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Moderne Bildgebungsverfahren beim Multiplen Myelom

    Bannas, P., Kröger, N., Adam, G. & Derlin, T., 01.01.2013, In: ROFO-FORTSCHR RONTG. 185, 1, p. 26-33 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Aktuelle Therapieoptionen bei der Myelofibrose

    Kröger, N-M., 2013, Aktuelle Therapieoptionen bei der Myelofibrose. Döhner, K. & Griesshammer, M. (eds.). 2 ed. Uni-Med, p. 56-63 7 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesTransferpeer-review

  37. Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings.

    Kröger, N., Zabelina, T., de Wreede, L., Berger, J., Alchalby, H., van Biezen, A., Milpied, N., Volin, L., Mohty, M., Leblond, V., Blaise, D., Finke, J., Schaap, N., Robin, M., de Witte, T. & European Group for Blood and Marrow Transplantation, 2013, In: LEUKEMIA. 27, 3, p. 604-609 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT.

    Martino, R., de Wreede, L., Fiocco, M., van Biezen, A., von Dem Borne, P. A., Hamladji, R-M., Volin, L., Bornhäuser, M., Robin, M., Rocha, V., de Witte, T., Kröger, N., Mohty, M. & European Group for Blood and Marrow Transplantation, 2013, In: BONE MARROW TRANSPL. 48, 6, p. 761-770 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Cytogenetics of extramedullary manifestations in multiple myeloma

    Billecke, L., Murga Penas, E. M., May, A. M., Engelhardt, M., Nagler, A., Leiba, M., Schiby, G., Kröger, N., Zustin, J., Marx, A., Matschke, J., Tiemann, M., Goekkurt, E., Heidtmann, H-H., Vettorazzi, E., Dierlamm, J., Bokemeyer, C. & Schilling, G., 2013, In: BRIT J HAEMATOL. 161, 1, p. 87-94 8 p., 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib.

    Koch, M., Graeser, C., Lehnhardt, A., Pollok, J-M., Kröger, N-M., Verboom, M., Thaiss, F., Eiermann, T. & Nashan, B., 2013, In: TRANSPL INT. 26, 8, p. 64-68 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.

    Kröger, N-M., Badbaran, A., Zabelina, T., Ayuketang, F. A., Wolschke, C., Alchalby, H., Klyuchnikov, E., Atanackovic, D., Schilling, G., Hansen, T., Schwarz, S., Heinzelmann, M., Zeschke, S., Bacher, U., Stübig, T., Fehse, B. & Zander, A. R., 2013, In: BIOL BLOOD MARROW TR. 19, 3, p. 398-404 7 p., 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia.

    van Gelder, M., de Wreede, L. C., Schetelig, J., van Biezen, A., Volin, L., Maertens, J., Robin, M., Petersen, E., de Witte, T., Kröger, N. & EBMT Chronic Malignancies Working Party, 2013, In: LEUKEMIA. 27, 4, p. 879-888 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.

    Oyekunle, A., Zander, A. R., Binder, M., Ayuketang, F. A., Zabelina, T., Christopeit, M., Stübig, T., Alchalby, H., Schafhausen, P., Lellek, H., Wolschke, C., Müller, I., Bacher, U. & Kröger, N-M., 2013, In: ANN HEMATOL. 92, 4, p. 487-496 10 p., 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.

    Wolschke, C., Stübig, T., Hegenbart, U., Schönland, S., Heinzelmann, M., Hildebrandt, Y., Ayuketang Ayuk, F., Atanackovic, D., Dreger, P., Zander, A. & Kröger, N., 2013, In: EXP HEMATOL. 41, 2, p. 133-134 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation.

    Roos-Weil, D., Dietrich, S., Boumendil, A., Polge, E., Bron, D., Carreras, E., Arturo, I. A., Arcese, W., Beelen, D. W., Cornelissen, J. J., Kröger, N., Milone, G., Rossi, G., Jardin, F., Peters, C., Rocha, V., Sureda, A., Mohty, M., Dreger, P. & European Group for Blood and Marrow Transplantation, 2013, In: BLOOD. 121, 3, p. 440-446

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.

    Kröger, N., Zabelina, T., Klyuchnikov, E., Kropff, M., Pflüger, K-H., Burchert, A., Stübig, T., Wolschke, C., Ayuketang, F. A., Hildebrandt, Y., Bacher, U., Badbaran, A., Schilling, G., Hansen, T., Atanackovic, D. & Zander, A. R., 2013, In: BONE MARROW TRANSPL. 48, 3, p. 403-407 5 p., 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. 2012
  48. Evaluation of BM cytomorphology after allo-SCT in patients with AML

    Christopeit, M., Miersch, K., Klyuchnikov, E., Haferlach, T., Binder, M., Zabelina, T., Ayuketang Ayuk, F., Schafhausen, P., Zander, A. R., Bokemeyer, C., Kröger, N. & Bacher, U., 12.2012, In: BONE MARROW TRANSPL. 47, 12, p. 1538-1544 7 p., 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.

    Finke, J., Schmoor, C., Bethge, W. A., Ottinger, H. D., Stelljes, M., Zander, A. R., Volin, L., Heim, D. A., Schwerdtfeger, R., Kolbe, K., Mayer, J., Maertens, J. A., Linkesch, W., Holler, E., Koza, V., Bornhäuser, M., Einsele, H., Bertz, H., Grishina, O., Socié, G., ATG-Fresenius Trial Group & Kröger, N-M., 01.11.2012, In: BIOL BLOOD MARROW TR. 18, 11, p. 1716-1726 11 p., 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.

    Le Gouill, S., Kröger, N., Dhedin, N., Nagler, A., Bouabdallah, K., Yakoub-Agha, I., Kanouni, T., Bulabois, C. E., Tournilhac, O., Buzyn, A., Rio, B., Moles, M. P., Shimoni, A., Bacher, U., Ocheni, S., Milpied, N., Harousseau, J. L., Moreau, P., Leux, C. & Mohty, M., 01.10.2012, In: ANN ONCOL. 23, 10, p. 2695-2703 9 p., 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

    Bornhäuser, M., Kienast, J., Trenschel, R., Burchert, A., Hegenbart, U., Stadler, M., Baurmann, H., Schäfer-Eckart, K., Holler, E., Kröger, N., Schmid, C., Einsele, H., Kiehl, M. G., Hiddemann, W., Schwerdtfeger, R., Buchholz, S., Dreger, P., Neubauer, A., Berdel, W. E., Ehninger, G., Beelen, D. W., Schetelig, J. & Stelljes, M., 01.10.2012, In: LANCET ONCOL. 13, 10, p. 1035-1044 10 p., 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Allogene Blutstammzelltransplantation

    Kröger, N., 2012, Multiples Myelom: Moderne Diagnoseverfahren, aktuelle Behandlungsoptionen und Supportivtherapie. Deutscher Ärzte-Verlag, p. 105-116 12 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  53. Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome.

    Kröger, N., 2012, In: BLOOD. 119, 24, p. 5632-5639 8 p., 24.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review